ArticleNeuro-oncology advances

Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma.

Sonoko Oshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.